Table 1.
RAD51 Expression | p | ||
---|---|---|---|
(−) | (+) | ||
Total | 39 (81.2) | 9 (18.8) | |
Age | 0.741 | ||
≤60 | 15 (78.9) | 4 (21.1) | |
>60 | 24 (82.8) | 5 (17.2) | |
BMI | 0.517 | ||
≤25 | 26 (78.8) | 7 (21.2) | |
>25 | 13 (86.7) | 2 (13.3) | |
T stage | 0.027 | ||
T 1 | 0 (0.0) | 2 (100.0) | |
T 2 | 5 (83.3) | 1 (16.7) | |
T 3 | 26 (83.9) | 5 (16.1) | |
T 4 | 8 (88.9) | 1(11.1) | |
N stage | 0.957 | ||
N 0 | 23 (82.1) | 5 (17.9) | |
N 1 | 9 (81.8) | 2 (18.2) | |
N 2 | 7 (77.8) | 2 (22.2) | |
CEA (ng/mL) | 0.716 | ||
≤5 | 28 (80.0) | 7 (20.0) | |
>5 | 11 (84.6) | 2 (15.4) | |
Differentiation | 0.111 | ||
Well-differentiated | 1 (50.0) | 1 (50.0) | |
Moderately differentiated | 36 (85.7) | 6 (14.3) | |
Poorly differentiated | 2 (50.0) | 2 (50.0) | |
Lymphovascular invasion | 0.348 | ||
(−) | 15 (75.0) | 5 (25.0) | |
(+) | 24 (85.7) | 4 (14.3) | |
Perineural invasion | 0.091 | ||
(−) | 23 (74.2) | 8 (25.8) | |
(+) | 16 (94.1) | 1 (5.9) |